M.D.C. Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

M.D.C. Holdings wird ein jährliches Gewinn- und Umsatzwachstum von 8% bzw. 6.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 7.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 13% betragen.

Wichtige Informationen

8.0%

Wachstumsrate der Gewinne

7.2%

EPS-Wachstumsrate

Consumer Durables Gewinnwachstum9.0%
Wachstumsrate der Einnahmen6.6%
Zukünftige Eigenkapitalrendite13.0%
Analystenabdeckung

Low

Zuletzt aktualisiert19 Apr 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

M.D.C. Sells To Sekisui At An Attractive Price; Further Upside Is Unlikely

Jan 18

Earnings Working Against M.D.C. Holdings, Inc.'s (NYSE:MDC) Share Price

Jan 03
Earnings Working Against M.D.C. Holdings, Inc.'s (NYSE:MDC) Share Price

We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Dec 18
We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Returns On Capital At M.D.C. Holdings (NYSE:MDC) Have Hit The Brakes

Nov 18
Returns On Capital At M.D.C. Holdings (NYSE:MDC) Have Hit The Brakes

M.D.C. Holdings: Navigating Through A Tough Housing Market

Nov 17

Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

Nov 03
Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

M.D.C. Holdings, Inc.'s (NYSE:MDC) Intrinsic Value Is Potentially 24% Below Its Share Price

Sep 22
M.D.C. Holdings, Inc.'s (NYSE:MDC) Intrinsic Value Is Potentially 24% Below Its Share Price

M.D.C. Holdings: Awaiting Q3 Results To Validate If Earnings Normalization Phase Has Started

Sep 06

We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Sep 05
We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Upgrade: Analysts Just Made A Substantial Increase To Their M.D.C. Holdings, Inc. (NYSE:MDC) Forecasts

Aug 01
Upgrade: Analysts Just Made A Substantial Increase To Their M.D.C. Holdings, Inc. (NYSE:MDC) Forecasts

Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

Jul 28
Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

We Like These Underlying Return On Capital Trends At M.D.C. Holdings (NYSE:MDC)

Jul 13
We Like These Underlying Return On Capital Trends At M.D.C. Holdings (NYSE:MDC)

M.D.C. Holdings: Not The Best Financially But Has A Margin Of Safety

Jul 09

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

Jun 05
Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

M.D.C. Holdings: Trends Are Turning, But Better To Wait And See

May 26

M.D.C. Holdings' (NYSE:MDC) Dividend Will Be $0.50

Apr 21
M.D.C. Holdings' (NYSE:MDC) Dividend Will Be $0.50

When Should You Buy M.D.C. Holdings, Inc. (NYSE:MDC)?

Apr 14
When Should You Buy M.D.C. Holdings, Inc. (NYSE:MDC)?

Returns on Capital Paint A Bright Future For M.D.C. Holdings (NYSE:MDC)

Mar 30
Returns on Capital Paint A Bright Future For M.D.C. Holdings (NYSE:MDC)

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

Mar 07
Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

M.D.C. Holdings: Near-Term Concerns May Weigh On Share Price Performance

Feb 08

M.D.C. Q4 2022 Earnings Preview

Jan 30

M.D.C. Holdings (NYSE:MDC) Will Pay A Dividend Of $0.50

Jan 28
M.D.C. Holdings (NYSE:MDC) Will Pay A Dividend Of $0.50

M.D.C. Holdings declares $0.50 dividend

Jan 24

M.D.C. Holdings, Inc. (NYSE:MDC) Shares Could Be 24% Above Their Intrinsic Value Estimate

Jan 13
M.D.C. Holdings, Inc. (NYSE:MDC) Shares Could Be 24% Above Their Intrinsic Value Estimate

Is M.D.C. Holdings, Inc. (NYSE:MDC) Potentially Undervalued?

Dec 29
Is M.D.C. Holdings, Inc. (NYSE:MDC) Potentially Undervalued?

Returns On Capital Are A Standout For M.D.C. Holdings (NYSE:MDC)

Dec 13
Returns On Capital Are A Standout For M.D.C. Holdings (NYSE:MDC)

Gewinn- und Umsatzwachstumsprognosen

NYSE:MDC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20265,6725022692941
12/31/20255,3044762222471
12/31/20244,8854232893143
12/31/20234,643399518562N/A
9/30/20234,8163591,1621,185N/A
6/30/20235,1473961,3611,387N/A
3/31/20235,4984921,1861,214N/A
12/31/20225,718559877906N/A
9/30/20225,664642194222N/A
6/30/20225,523643-79-49N/A
3/31/20225,437608-63-32N/A
12/31/20215,255571-238-208N/A
9/30/20215,014555-168-139N/A
6/30/20214,750509-94-67N/A
3/31/20214,269439-70-44N/A
12/31/20203,901365-50-23N/A
9/30/20203,78131195120N/A
6/30/20203,5162633458N/A
3/31/20203,348233-59-34N/A
12/31/20193,2932373358N/A
9/30/20193,071199-918N/A
6/30/20193,08420276104N/A
3/31/20193,10321181108N/A
12/31/20183,065210-35-8N/A
9/30/20182,907180-83-63N/A
6/30/20182,726187-122-108N/A
3/31/20182,623158-93-85N/A
12/31/20172,5781416871N/A
9/30/20172,587157N/A199N/A
6/30/20172,580122N/A260N/A
3/31/20172,501115N/A225N/A
12/31/20162,327103N/A116N/A
9/30/20162,17685N/A18N/A
6/30/20162,04874N/A-66N/A
3/31/20161,93267N/A-30N/A
12/31/20151,90966N/A0N/A
9/30/20151,83658N/A-17N/A
6/30/20151,78658N/A-23N/A
3/31/20151,75560N/A-34N/A
12/31/20141,69863N/A-164N/A
9/30/20141,66177N/A-217N/A
6/30/20141,69197N/A-220N/A
3/31/20141,664299N/A-328N/A
12/31/20131,680309N/A-270N/A
9/30/20131,614310N/A-284N/A
6/30/20131,500294N/A-239N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: MDCDas prognostizierte Gewinnwachstum (8% pro Jahr) liegt über der Sparquote (2.3%).

Ertrag vs. Markt: MDCDie Erträge des Unternehmens (8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.4% pro Jahr).

Hohe Wachstumserträge: MDCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: MDCDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: MDCDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: MDCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (13%).


Wachstumsunternehmen entdecken